[Pneumocystis: epidemiology and molecular approaches]

Area of Science:

• Medical Mycology
• Infectious Diseases
• Molecular Diagnostics

Context:

• Pneumocystosis is a significant opportunistic infection in immunocompromised individuals, particularly those with AIDS.
• Traditional diagnostic methods for Pneumocystis pneumonia (PCP) suffer from low sensitivity and lack of culturing techniques.
• The environmental presence and transmission routes of Pneumocystis remain incompletely understood.

Purpose:

• To review the advancements in diagnosing Pneumocystis pneumonia using molecular biology techniques.
• To explore the application of molecular methods in detecting Pneumocystis DNA in diverse sample types and environmental sources.
• To discuss the genetic diversity of Pneumocystis strains and the implications for treatment resistance.

Summary:

• Molecular techniques, especially Polymerase Chain Reaction (PCR), have enhanced the detection of Pneumocystis jirovecii DNA in both clinical and environmental samples.
• These methods have provided insights into human transmission and environmental reservoirs of Pneumocystis.
• Molecular typing has revealed significant genetic biodiversity within P. jirovecii strains.
• The increasing use of cotrimoxazole has prompted investigations into potential sulfa drug resistance in P. jirovecii.

Impact:

• Improved diagnostic accuracy and earlier detection of Pneumocystis pneumonia.
• Better understanding of Pneumocystis transmission dynamics and environmental epidemiology.
• Foundation for further research into Pneumocystis strain variation and antimicrobial resistance.
• Informing clinical management strategies for immunocompromised patients at risk of PCP.